Response to: Genetic risk scores may compound rather than solve the issue of prostate cancer overdiagnosis (BJC-LT3342090).
Br J Cancer
; 128(4): 487-488, 2023 02.
Article
de En
| MEDLINE
| ID: mdl-36536048
Texte intégral:
1
Collection:
01-internacional
Base de données:
MEDLINE
Sujet principal:
Tumeurs de la prostate
/
Surdiagnostic
Type d'étude:
Etiology_studies
/
Risk_factors_studies
Limites:
Humans
/
Male
Langue:
En
Journal:
Br J Cancer
Année:
2023
Type de document:
Article
Pays d'affiliation:
Royaume-Uni